Buckinghamshire Healthcare NHS Trust   Report issue

Government Phase 2 Phase 4
Founded: United Kingdom

Organization Overview

First Clinical Trial
2011
NCT01398995
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Bcukinghamshire Healthcare NHS Trust | Buckinghamshire Healthcare NHS Trust

Active Ingredients

Drugs in Phase 4 Trials (2)

insulin detemir (Levemir) (1 trial)

insulin glargine (toujeo) (1 trial)

Drugs in Phase 2 Trials (2)

carboplatin (paraplatin) (1 trial)

uro vaxom (1 trial)

Drugs in Other Trials (1)

insulin human (humulin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Prostatic Neoplasms (Phase 2)

Urinary Bladder, Neurogenic (Phase 2)

Urinary Tract Infections (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5